US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
SDEV
$7.48
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
SDEV
$7.48
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by DiaMedica Therapeutics
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
July 06, 2022
From
DiaMedica Therapeutics
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Attend the 19th Annual Craig-Hallum Institutional Investor Conference Wednesday, June 1, 2022
May 25, 2022
From
DiaMedica Therapeutics
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
July 28, 2021
From
DiaMedica Therapeutics
Via
Business Wire
Tickers
DMAC
